Combining DNA Vaccine and AIM2 in H1 Nanoparticles Exert Anti-Renal Carcinoma Effects via Enhancing Tumor-Specific Multi-Functional CD8+ T Cell Responses
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0832
Full Text
Open PDFAbstract
Available in full text
Date
November 6, 2018
Authors
Publisher
American Association for Cancer Research (AACR)